News

News
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story
Partner news

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

Read full story
Partner news

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story
Partner news

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

Read full story
In the media

Janssen on driving R&D innovation with data science

Read full story
Partner news

Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research

Read full story
In the media

Mestag Therapeutics

Read full story
In the media

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
In the media

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story
Partner news

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Read full story
Partner news

L'engagement de Janssen France dans l'IA et la génomique

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story